Dear Sir: I came across your blog after reading Stanley Bing’s recent article in Fortune Magazine. I will try to be brief. I have a 4 year old son who was diagnosed 1.5 years ago with a form of Leigh’s disease; one of the most devastating forms of mitochondrial disease. While he is receiving care… Continue reading Leigh syndrome – where are those mitochondria replacement therapies?
UK scientists in artificial skin breakthrough: “A long-lasting artificial skin has been developed by British researchers. The Cambridge-based Intercytex Group Plc has announced that tests had produced promising results in healing wounds in early clinical trials…. ICX-SKN is created from a matrix produced by the same skin cells that are responsible for synthesising new tissue… Continue reading Off-the-shelf skin replacements are on their way…
The trendy cancer stem cell theory highlights that there is a functional hierarchy between different tumour cells and only a small portion, the so called cancer stem cells have crucial role in initiating tumour growth. This assumption was confirmed in the case of blood, breast and brain for example. Based on that a new therapeutic… Continue reading Redifferentiating brain tumour stem cells: the concept of cancer regenerative medicine
Critical thinking is crucial to every successful scientific and technological project. In order to consider any attempt to the extension of life in details,we have to take a look at the other side of the coin. So in the future I try to blogterview some experts, scholars, philosophers, activists, …who are opposing some concrete points… Continue reading Questions to contra life extensionists: rational pitfalls
Dina Gould Halme and David A. Kessler wrote an article, called FDA Regulation of Stem-Cell–Based Therapies in The New England Journal of Medicine. The key concerns are: i., Stem-cell–based products as therapeutic agents are or could be: biologic products, drugs, devices, xenotransplantation products, human cells, tissues, and cellular and tissue-based products. Human cells, tissues, and… Continue reading FDA Stem Cell Therapy Regulation: the Framework
A new book coedited by UC Santa Cruz Literature and Anthropology professors Helene Moglen and Nancy Chen, Bodies in the Making: Transgressions and Transformations, explores a range of practices that aren’t usually linked: tattooing, cosmetic surgery, body-building, life extension technologies, self-cutting. The common denominator is intended to be body hacking, modification and our fascination with… Continue reading Bodies in the Making book, essays by UC Santa Cruz professors
As I mentioned before, continuous regeneration treatment of the whole human body called Pimm could be interpreted as inside plastic surgery for functional reasons. And now here comes one nice example of the present biotech trend:
From Investor’s Business Daily: Big pharmaceutical firms and major biotechs are holding back as well, William Caldwell CEO of Advanced Cell Technology says. “While all of them have stem cell development labs someplace in the bowels of their organizations, they are not putting capital into the sector.” These companies are nervous about the political and… Continue reading U.S. stem cell companies: a new roundup
Deep story by Kerry Howley, associate editor of Reason Magazine, aka “Donor #15” who sold 12 ova to a pair of strangers for $10,000. From the story: By the mid-1980s, babies were being born via donated eggs that were fertilized outside the womb and later implanted in women incapable of producing viable ova. If you… Continue reading Human Egg Market: the naked truth
Today’s bioWired story is What if bionics were better on what-if scenarios in body hack by Chris Oakes. Bionic in the present sense refers to having particular physiological functions augmented or replaced by electronic or electromechanical components. The article covers recent bionic projects like Cyberhand the European multidisciplinary hand prosthesis for amputees, and EyeTap, an… Continue reading Wired’s bionic tour over your body
In the last philosophical-political section of Pimm I tried to delineate how to protect the right for partial immortalization when the costs of the treatment are extremely high. After it turned out that on the grounds of equal dignity it is hard to make the treatment impossible for those, who can afford it, the second… Continue reading Can partial immortalization be permissible to those who can buy it?